Getinge AB (publ) (GNGBF)
USD 15.68
(0.0%)
USD 15.68
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 13.51 Billion SEK | 0.81% |
| 2022 | 13.4 Billion SEK | -1.26% |
| 2021 | 13.58 Billion SEK | -7.76% |
| 2020 | 14.72 Billion SEK | 18.2% |
| 2019 | 12.45 Billion SEK | 12.68% |
| 2018 | 11.05 Billion SEK | 4.25% |
| 2017 | 10.6 Billion SEK | -23.4% |
| 2016 | 13.84 Billion SEK | -2.28% |
| 2015 | 14.16 Billion SEK | 8.03% |
| 2014 | 13.11 Billion SEK | -0.11% |
| 2013 | 13.12 Billion SEK | 3.31% |
| 2012 | 12.7 Billion SEK | 11.42% |
| 2011 | 11.4 Billion SEK | 0.27% |
| 2010 | 11.37 Billion SEK | 1.06% |
| 2009 | 11.25 Billion SEK | 20.56% |
| 2008 | 9.33 Billion SEK | 17.56% |
| 2007 | 7.93 Billion SEK | 30.25% |
| 2006 | 6.09 Billion SEK | 11.66% |
| 2005 | 5.45 Billion SEK | 7.9% |
| 2004 | 5.05 Billion SEK | 22.94% |
| 2003 | 4.11 Billion SEK | 7.86% |
| 2002 | 3.81 Billion SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 3.65 Billion SEK | 0.69% |
| 2024 Q1 | 3.63 Billion SEK | -9.38% |
| 2024 Q3 | 3.55 Billion SEK | -2.82% |
| 2023 Q2 | 3.09 Billion SEK | -11.94% |
| 2023 Q1 | 3.51 Billion SEK | -8.05% |
| 2023 Q4 | 4 Billion SEK | 11.64% |
| 2023 Q3 | 3.59 Billion SEK | 15.88% |
| 2023 FY | 13.51 Billion SEK | 0.81% |
| 2022 Q1 | 3.05 Billion SEK | -22.51% |
| 2022 Q4 | 3.82 Billion SEK | 13.22% |
| 2022 FY | 13.4 Billion SEK | -1.26% |
| 2022 Q3 | 3.38 Billion SEK | 7.34% |
| 2022 Q2 | 3.14 Billion SEK | 3.14% |
| 2021 Q4 | 3.94 Billion SEK | 25.76% |
| 2021 FY | 13.58 Billion SEK | -7.76% |
| 2021 Q3 | 3.13 Billion SEK | -8.58% |
| 2021 Q2 | 3.42 Billion SEK | 11.27% |
| 2021 Q1 | 3.08 Billion SEK | -25.93% |
| 2020 Q4 | 4.15 Billion SEK | 0.68% |
| 2020 Q2 | 3.45 Billion SEK | 16.2% |
| 2020 Q1 | 2.97 Billion SEK | -26.63% |
| 2020 FY | 14.72 Billion SEK | 18.2% |
| 2020 Q3 | 4.13 Billion SEK | 19.43% |
| 2019 Q3 | 2.93 Billion SEK | 2.23% |
| 2019 Q4 | 4.05 Billion SEK | 38.29% |
| 2019 Q1 | 2.59 Billion SEK | -27.36% |
| 2019 Q2 | 2.86 Billion SEK | 10.47% |
| 2019 FY | 12.45 Billion SEK | 12.68% |
| 2018 Q3 | 2.42 Billion SEK | -8.82% |
| 2018 Q2 | 2.65 Billion SEK | 10.4% |
| 2018 Q1 | 2.4 Billion SEK | 261.5% |
| 2018 FY | 11.05 Billion SEK | 4.25% |
| 2018 Q4 | 3.57 Billion SEK | 47.73% |
| 2017 Q3 | 3.19 Billion SEK | -7.42% |
| 2017 FY | 10.6 Billion SEK | -23.4% |
| 2017 Q4 | 665 Million SEK | -79.17% |
| 2017 Q1 | 3.29 Billion SEK | -24.89% |
| 2017 Q2 | 3.44 Billion SEK | 4.67% |
| 2016 Q3 | 3.27 Billion SEK | 3.41% |
| 2016 Q4 | 4.38 Billion SEK | 33.95% |
| 2016 FY | 13.84 Billion SEK | -2.28% |
| 2016 Q2 | 3.16 Billion SEK | 5.18% |
| 2016 Q1 | 3.01 Billion SEK | -32.34% |
| 2015 FY | 14.16 Billion SEK | 8.03% |
| 2015 Q4 | 4.45 Billion SEK | 37.35% |
| 2015 Q3 | 3.24 Billion SEK | -2.73% |
| 2015 Q2 | 3.33 Billion SEK | 6.02% |
| 2015 Q1 | 3.14 Billion SEK | -25.24% |
| 2014 FY | 13.11 Billion SEK | -0.11% |
| 2014 Q2 | 3.08 Billion SEK | 10.98% |
| 2014 Q1 | 2.77 Billion SEK | -32.26% |
| 2014 Q4 | 4.2 Billion SEK | 37.98% |
| 2014 Q3 | 3.04 Billion SEK | -1.2% |
| 2013 FY | 13.12 Billion SEK | 3.31% |
| 2013 Q4 | 4.1 Billion SEK | 38.83% |
| 2013 Q3 | 2.95 Billion SEK | -5.38% |
| 2013 Q2 | 3.12 Billion SEK | 5.94% |
| 2013 Q1 | 2.94 Billion SEK | -26.76% |
| 2012 Q4 | 4.02 Billion SEK | 37.81% |
| 2012 Q1 | 2.75 Billion SEK | -27.6% |
| 2012 Q2 | 3 Billion SEK | 9.15% |
| 2012 FY | 12.7 Billion SEK | 11.42% |
| 2012 Q3 | 2.92 Billion SEK | -2.86% |
| 2011 Q4 | 3.8 Billion SEK | 50.36% |
| 2011 FY | 11.4 Billion SEK | 0.27% |
| 2011 Q1 | 2.48 Billion SEK | -27.47% |
| 2011 Q2 | 2.58 Billion SEK | 4.03% |
| 2011 Q3 | 2.53 Billion SEK | -2.09% |
| 2010 Q3 | 2.62 Billion SEK | -6.48% |
| 2010 Q2 | 2.8 Billion SEK | 11.91% |
| 2010 Q1 | 2.51 Billion SEK | -25.76% |
| 2010 FY | 11.37 Billion SEK | 1.06% |
| 2010 Q4 | 3.42 Billion SEK | 30.38% |
| 2009 Q2 | 2.65 Billion SEK | 4.74% |
| 2009 FY | 11.25 Billion SEK | 20.56% |
| 2009 Q1 | 2.53 Billion SEK | 0.0% |
| 2009 Q4 | 3.38 Billion SEK | 25.73% |
| 2009 Q3 | 2.68 Billion SEK | 1.43% |
| 2008 FY | 9.33 Billion SEK | 17.56% |
| 2007 FY | 7.93 Billion SEK | 30.25% |
| 2006 FY | 6.09 Billion SEK | 11.66% |
| 2005 FY | 5.45 Billion SEK | 7.9% |
| 2004 FY | 5.05 Billion SEK | 22.94% |
| 2003 FY | 4.11 Billion SEK | 7.86% |
| 2002 FY | 3.81 Billion SEK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | -1000.00 USD | 1351800100.0% |
| Össur hf. | 485.57 Million USD | -2683.927% |
| QHSLab, Inc. | 793.6 Thousand USD | -1703261.992% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 485.57 Million USD | -2683.927% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 5.14 Million USD | -262579.667% |
| Aurora Spine Corporation | 8.21 Million USD | -164526.955% |
| BrainsWay Ltd. | 23.09 Million USD | -58442.289% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | -32327.078% |
| CVR Medical Corp. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 35.08 Million USD | -38431.042% |
| BioElectronics Corporation | 466.38 Thousand USD | -2898345.071% |
| Vivos Inc. | -6036.00 USD | 223956362.425% |
| Kelyniam Global, Inc. | 2.03 Million USD | -663823.484% |
| Zecotek Photonics Inc. | -195.32 Thousand USD | 6921014.802% |
| REMSleep Holdings, Inc. | -756.73 Thousand USD | 1786449.058% |
| EKF Diagnostics Holdings plc | 16.74 Million USD | -80632.312% |
| Avitar, Inc. | 836.7 Thousand USD | -1615528.981% |
| Nanomix Corporation | -69.45 Thousand USD | 19462220.994% |
| Theraclion SA | -1.08 Million USD | 1251320.63% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 587.55 Thousand USD | -2300640.363% |
| NewCardio, Inc. | 105.1 Thousand USD | -12861569.029% |
| Positron Corporation | -353.46 Thousand USD | 3824523.918% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.04 Million USD | -1292863.687% |
| Lombard Medical, Inc. | 955 Thousand USD | -1415397.382% |
| ALR Technologies Inc. | 4945.00 USD | -273366937.412% |
| Stratec SE | 71.58 Million USD | -18782.881% |
| Vycor Medical, Inc. | 1.31 Million USD | -1027373.789% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | -12.9 Thousand USD | 104790797.674% |
| MicroPort Scientific Corporation | 532.09 Million USD | -2440.509% |
| VMS Rehab Systems, Inc. | -10.44 USD | 129482758720.69% |
| Guided Therapeutics, Inc. | 36 Thousand USD | -37549900.0% |
| Ingen Technologies, Inc. | 268.57 Thousand USD | -5033074.72% |
| CYduct Diagnostics, Inc. | 56.59 Thousand USD | -23885824.303% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| SANUWAVE Health, Inc. | 14.36 Million USD | -94016.828% |
| IR-Med Inc. | -17 Thousand USD | 79517747.059% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -6548715.758% |
| United American Healthcare Corporation | -8000.00 USD | 168975100.0% |
| Polarean Imaging plc | 335.48 Thousand USD | -4029314.307% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 1.09 Million USD | -1235495.911% |
| Medical Supply International USA, Inc. | 1.75 Million USD | -768545.539% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | -316.69 Thousand USD | 4268614.104% |
| SS Innovations International, Inc. | 713.44 Thousand USD | -1894644.809% |
| Urologix, Inc. | 6.09 Million USD | -221761.152% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 3.91 Billion USD | -245.64% |
| NIOX Group Plc | 28.13 Million USD | -47949.82% |
| Fuse Medical, Inc. | 10.73 Million USD | -125838.178% |
| Broncus Holding Corporation | 7.22 Million USD | -186948.568% |
| Brain Scientific Inc. | 54.32 Thousand USD | -24883471.1% |
| Pressure BioSciences, Inc. | 799.56 Thousand USD | -1690575.645% |
| Health Logic Interactive Inc. | - USD | -Infinity% |